Merck, Sandoz Resolve Patent Suit Over Cancidas

Law360, New York (June 30, 2011, 1:51 PM EDT) -- A New Jersey federal judge on Wednesday dismissed one of two patent lawsuits over Sandoz Inc.'s plans for a generic version of Merck & Co. Inc.'s anti-fungal medication Cancidas.

U.S. District Judge Stanley Chesler signed off on a joint stipulation of dismissal filed by the companies. The case had been consolidated with another suit between the companies over the same product.

That case, which was filed earlier and involves a different patent, remains pending in the same court.

Merck first filed suit in March 2010, alleging...
To view the full article, register now.